top of page

New safer and shorter drug-resistant TB treatment must be scaled up

Médecins Sans Frontières (MSF) calls on governments and donors to speed up access to new, shorter, safer and more effective treatments for drug-resistant tuberculosis (DR-TB). MSF joined the World Health Organization (WHO) and other organisations in a ‘Call to Action’ ahead of World TB Day. MSF also urges the US-based diagnostics corporation Cepheid to drop the price of the critical GeneXpert tests, and for governments to scale up access to diagnostic test, to ensure that people with DR-TB can be diagnosed in time to access the shorter and safer treatment regimens. Read more here.

16 views0 comments

Recent Posts

See All

John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks

bottom of page